{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:17:50Z","timestamp":1779164270339,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126632","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T20:26:28Z","timestamp":1734639988000},"page":"126632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Evaluation of the toxoplasma Urm1 gene deletion mutant (Pru\u0394Urm1) as a promising vaccine candidate against toxoplasmosis in mice"],"prefix":"10.1016","volume":"45","author":[{"given":"Shu","family":"Bian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingxiu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nianyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningning","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.vaccine.2024.126632_bb0005","doi-asserted-by":"crossref","first-page":"R770","DOI":"10.1016\/j.cub.2018.05.035","article-title":"Toxoplasma gondii","volume":"28","author":"Kochanowsky","year":"2018","journal-title":"Curr Biol"},{"issue":"9425","key":"10.1016\/j.vaccine.2024.126632_bb0010","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126632_bb0015","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","article-title":"Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease","volume":"172","author":"Howe","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126632_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.842595","article-title":"Toxoplasma gondii genotyping: a closer look into Europe","volume":"12","author":"Fern\u00e1ndez-Escobar","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126632_bb0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-3024.1993.tb00616.x","article-title":"Influence of genes within the MHC on mortality and brain cyst development in mice infected with toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice","volume":"15","author":"Blackwell","year":"1993","journal-title":"Parasite Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126632_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02394-21","article-title":"Involvement of Urm1, a ubiquitin-like protein, in the regulation of oxidative stress response of toxoplasma gondii","volume":"10","author":"Tan","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2024.126632_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2009.02.026","article-title":"Toxoplasmosis in sheep--the last 20 years","volume":"163","author":"Dubey","year":"2009","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2024.126632_bb0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vetpar.2019.04.012","article-title":"The global seroprevalence of toxoplasma gondii in pigs: a systematic review and meta-analysis","volume":"269","author":"Foroutan","year":"2019","journal-title":"Vet Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126632_bb0045","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126632_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126632_bb0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pt.2019.01.005","article-title":"Advances in the development of anti-toxoplasma gondii vaccines: challenges, opportunities, and perspectives","volume":"35","author":"Wang","year":"2019","journal-title":"Trends Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126632_bb0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00430-015-0447-5","article-title":"Immunity in the spleen and blood of mice immunized with irradiated toxoplasma gondii tachyzoites","volume":"205","author":"Zorgi","year":"2016","journal-title":"Med Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126632_bb0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.parint.2018.02.002","article-title":"Disodium cromoglycate may act as a novel adjuvant for UV-attenuated toxoplasma gondii vaccine in mouse model","volume":"67","author":"Li","year":"2018","journal-title":"Parasitol Int"},{"key":"10.1016\/j.vaccine.2024.126632_bb0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fcimb.2017.00142","article-title":"Recombinant TgHSP70 immunization protects against toxoplasma gondii brain cyst formation by enhancing inducible nitric oxide expression","volume":"7","author":"Czarnewski","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2024.126632_bb0075","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3389\/fmicb.2016.00808","article-title":"Induction of protective immunity against toxoplasmosis in BALB\/c mice vaccinated with toxoplasma gondii Rhoptry-1","volume":"7","author":"Sonaimuthu","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.126632_bb0080","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3389\/fimmu.2018.01814","article-title":"A lactate fermentation mutant of toxoplasma stimulates protective immunity against acute and chronic toxoplasmosis","volume":"9","author":"Xia","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126632_bb0085","doi-asserted-by":"crossref","first-page":"e01114","DOI":"10.1128\/mBio.01114-14","article-title":"Efficient gene disruption in diverse strains of toxoplasma gondii using CRISPR\/CAS9","volume":"5","author":"Shen","year":"2014","journal-title":"MBio"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126632_bb0090","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/infdis\/jiy211","article-title":"Live attenuated Pru:\u0394cdpk2 strain of toxoplasma gondii protects against acute, chronic, and congenital toxoplasmosis","volume":"218","author":"Wang","year":"2018","journal-title":"J Infect Dis"},{"issue":"5564","key":"10.1016\/j.vaccine.2024.126632_bb0095","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1126\/science.1069989","article-title":"Role of a ubiquitin-like modification in polarized morphogenesis","volume":"295","author":"Dittmar","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.126632_bb0100","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3389\/fmicb.2019.02039","article-title":"URM1-mediated ubiquitin-like modification is required for oxidative stress adaptation during infection of the Rice blast fungus","volume":"10","author":"Wang","year":"2019","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126632_bb0105","article-title":"Influenza a virus weakens the immune response of mice to toxoplasma gondii, thereby aggravating T. Gondii infection","volume":"10","author":"Chen","year":"2023","journal-title":"Vet Sci"},{"key":"10.1016\/j.vaccine.2024.126632_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.exppara.2017.01.009","article-title":"On the determination of toxoplasma gondii virulence in mice","volume":"174","author":"Saraf","year":"2017","journal-title":"Exp Parasitol"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126632_bb0115","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/1751-7915.14324","article-title":"Role of 6-phosphogluconate dehydrogenase enzyme 1 in growth and virulence of toxoplasma gondii and development of attenuated live vaccine","volume":"16","author":"Guo","year":"2023","journal-title":"Microb Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126632_bb0120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41467-024-44967-z","article-title":"The transcription factor AP2XI-2 is a key negative regulator of toxoplasma gondii merogony","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126632_bb0125","first-page":"229","article-title":"In vitro culture of toxoplasma gondii tachyzoites in HFF and HeLa cells","volume":"27","author":"Wu","year":"2009","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126632_bb0130","article-title":"Deletion of toxoplasma Rhoptry protein 38 (Pru\u0394rop38) as a vaccine candidate for toxoplasmosis in a murine model","volume":"10","author":"Wu","year":"2022","journal-title":"Biomedicine"},{"issue":"Pt B","key":"10.1016\/j.vaccine.2024.126632_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbr.2015.11.005","article-title":"Induction of depression-related behaviors by reactivation of chronic toxoplasma gondii infection in mice","volume":"298","author":"Mahmoud","year":"2016","journal-title":"Behav Brain Res"},{"issue":"8","key":"10.1016\/j.vaccine.2024.126632_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0020084","article-title":"Toxoplasma MIC2 is a major determinant of invasion and virulence","volume":"2","author":"Huynh","year":"2006","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126632_bb0145","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13071-024-06339-w","article-title":"Toxoplasma gondii bradyzoite-specific BAG1 is nonessential for cyst formation due to compensation by other heat-shock proteins","volume":"17","author":"Wu","year":"2024","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2024.126632_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2019.105148","article-title":"Vaccination with recombinant toxoplasma gondii CDPK3 induces protective immunity against experimental toxoplasmosis","volume":"199","author":"Wu","year":"2019","journal-title":"Acta Trop"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126632_bb0155","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.4049\/jimmunol.151.7.3672","article-title":"Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation","volume":"151","author":"Gazzinelli","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.126632_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2019.102049","article-title":"T cell-derived interferon-\u03b3 is required for host defense to toxoplasma gondii","volume":"75","author":"Nishiyama","year":"2020","journal-title":"Parasitol Int"},{"issue":"4851","key":"10.1016\/j.vaccine.2024.126632_bb0165","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-gamma: the major mediator of resistance against toxoplasma gondii","volume":"240","author":"Suzuki","year":"1988","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126632_bb0170","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.189.7.1083","article-title":"Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen","volume":"189","author":"Yap","year":"1999","journal-title":"Toxoplasma gondii J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126632_bb0175","first-page":"798","article-title":"In the absence of endogenous IL-10, mice acutely infected with toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12","volume":"157","author":"Gazzinelli","year":"1996","journal-title":"IFN-gamma and TNF-alpha J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126632_bb0180","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/IAI.02606-14","article-title":"AMA1-deficient toxoplasma gondii parasites transiently colonize mice and trigger an innate immune response that leads to long-lasting protective immunity","volume":"83","author":"Lagal","year":"2015","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24013148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24013148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T15:13:03Z","timestamp":1739200383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24013148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":36,"alternative-id":["S0264410X24013148"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126632","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the toxoplasma Urm1 gene deletion mutant (Pru\u0394Urm1) as a promising vaccine candidate against toxoplasmosis in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126632"}}